BRPI0921795A2 - inibidores radiomarcados do transportador de glicina 1 - Google Patents
inibidores radiomarcados do transportador de glicina 1Info
- Publication number
- BRPI0921795A2 BRPI0921795A2 BRPI0921795A BRPI0921795A BRPI0921795A2 BR PI0921795 A2 BRPI0921795 A2 BR PI0921795A2 BR PI0921795 A BRPI0921795 A BR PI0921795A BR PI0921795 A BRPI0921795 A BR PI0921795A BR PI0921795 A2 BRPI0921795 A2 BR PI0921795A2
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- glycine transporter
- radiolabelled
- radiolabelled glycine
- transporter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08168229.6 | 2008-11-04 | ||
| EP08168229 | 2008-11-04 | ||
| PCT/EP2009/064033 WO2010052143A1 (en) | 2008-11-04 | 2009-10-26 | Radiolabelled inhibitors of the glycine 1 transporter |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0921795A2 true BRPI0921795A2 (pt) | 2016-01-12 |
| BRPI0921795B1 BRPI0921795B1 (pt) | 2020-10-20 |
| BRPI0921795B8 BRPI0921795B8 (pt) | 2021-07-27 |
Family
ID=41402176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0921795A BRPI0921795B8 (pt) | 2008-11-04 | 2009-10-26 | inibidores radiomarcados do transportador de glicina 1 e seu uso |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8153679B2 (pt) |
| EP (1) | EP2342197B1 (pt) |
| JP (1) | JP5543477B2 (pt) |
| KR (1) | KR101307671B1 (pt) |
| CN (1) | CN102186844B (pt) |
| AR (1) | AR074084A1 (pt) |
| AU (1) | AU2009312891B2 (pt) |
| BR (1) | BRPI0921795B8 (pt) |
| CA (1) | CA2739869C (pt) |
| CL (1) | CL2011000982A1 (pt) |
| DK (1) | DK2342197T3 (pt) |
| ES (1) | ES2401221T3 (pt) |
| IL (1) | IL211804A (pt) |
| MX (1) | MX2011004350A (pt) |
| PE (1) | PE20110434A1 (pt) |
| PL (1) | PL2342197T3 (pt) |
| RU (1) | RU2512529C2 (pt) |
| SI (1) | SI2342197T1 (pt) |
| TW (1) | TWI449537B (pt) |
| WO (1) | WO2010052143A1 (pt) |
| ZA (1) | ZA201102521B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5618047B2 (ja) * | 2010-01-29 | 2014-11-05 | 国立大学法人千葉大学 | ポジトロン断層撮影法およびポジトロン放出化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1656361T1 (sl) | 2003-08-11 | 2008-04-30 | Hoffmann La Roche | Piperazin z OR-substituirano fenilno skupino in njuna uporaba kot zaviralca GLYT1 |
| MX2007009342A (es) * | 2005-02-07 | 2007-09-21 | Hoffmann La Roche | Fenil-metanonas sustituidas por heterociclo como inhibidor del transportador 1 de glicina. |
| EP1942733B1 (en) * | 2005-09-29 | 2012-03-21 | Merck Sharp & Dohme Corp. | Radiolabeled glycine transporter inhibitors |
-
2009
- 2009-10-26 JP JP2011533694A patent/JP5543477B2/ja not_active Expired - Fee Related
- 2009-10-26 EP EP09737459A patent/EP2342197B1/en active Active
- 2009-10-26 PE PE2011000892A patent/PE20110434A1/es active IP Right Grant
- 2009-10-26 AU AU2009312891A patent/AU2009312891B2/en not_active Ceased
- 2009-10-26 CA CA2739869A patent/CA2739869C/en not_active Expired - Fee Related
- 2009-10-26 CN CN200980141350.7A patent/CN102186844B/zh active Active
- 2009-10-26 BR BRPI0921795A patent/BRPI0921795B8/pt not_active IP Right Cessation
- 2009-10-26 KR KR1020117010147A patent/KR101307671B1/ko active IP Right Grant
- 2009-10-26 ES ES09737459T patent/ES2401221T3/es active Active
- 2009-10-26 RU RU2011118230/04A patent/RU2512529C2/ru active
- 2009-10-26 PL PL09737459T patent/PL2342197T3/pl unknown
- 2009-10-26 MX MX2011004350A patent/MX2011004350A/es active IP Right Grant
- 2009-10-26 WO PCT/EP2009/064033 patent/WO2010052143A1/en active Application Filing
- 2009-10-26 SI SI200930547T patent/SI2342197T1/sl unknown
- 2009-10-26 DK DK09737459.9T patent/DK2342197T3/da active
- 2009-10-28 US US12/607,111 patent/US8153679B2/en not_active Expired - Fee Related
- 2009-11-03 AR ARP090104237A patent/AR074084A1/es not_active Application Discontinuation
- 2009-11-03 TW TW098137279A patent/TWI449537B/zh not_active IP Right Cessation
-
2011
- 2011-03-17 IL IL211804A patent/IL211804A/en active IP Right Grant
- 2011-04-05 ZA ZA2011/02521A patent/ZA201102521B/en unknown
- 2011-05-03 CL CL2011000982A patent/CL2011000982A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8153679B2 (en) | 2012-04-10 |
| EP2342197A1 (en) | 2011-07-13 |
| CA2739869A1 (en) | 2011-05-14 |
| US20100111862A1 (en) | 2010-05-06 |
| JP2012507486A (ja) | 2012-03-29 |
| ES2401221T3 (es) | 2013-04-17 |
| TW201019964A (en) | 2010-06-01 |
| AR074084A1 (es) | 2010-12-22 |
| MX2011004350A (es) | 2011-05-23 |
| JP5543477B2 (ja) | 2014-07-09 |
| BRPI0921795B1 (pt) | 2020-10-20 |
| DK2342197T3 (da) | 2013-02-18 |
| AU2009312891B2 (en) | 2013-07-11 |
| IL211804A0 (en) | 2011-06-30 |
| CA2739869C (en) | 2016-09-27 |
| IL211804A (en) | 2013-11-28 |
| KR20110063861A (ko) | 2011-06-14 |
| WO2010052143A1 (en) | 2010-05-14 |
| PL2342197T3 (pl) | 2013-06-28 |
| EP2342197B1 (en) | 2013-01-16 |
| CN102186844A (zh) | 2011-09-14 |
| AU2009312891A1 (en) | 2010-05-14 |
| PE20110434A1 (es) | 2011-07-01 |
| TWI449537B (zh) | 2014-08-21 |
| RU2512529C2 (ru) | 2014-04-10 |
| CN102186844B (zh) | 2014-08-13 |
| KR101307671B1 (ko) | 2013-09-12 |
| CL2011000982A1 (es) | 2012-02-03 |
| BRPI0921795B8 (pt) | 2021-07-27 |
| SI2342197T1 (sl) | 2013-05-31 |
| RU2011118230A (ru) | 2012-12-20 |
| ZA201102521B (en) | 2012-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR22C1054I2 (fr) | Amides peptidiques synthetiques | |
| CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
| BRPI0911743A2 (pt) | "peptídeo" | |
| IT1394247B1 (it) | Dispositivo di serraggio | |
| CR10831A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
| BRPI0719204A2 (pt) | Inibidores de hdac | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| DK2042659T3 (da) | Forankringsstolpe | |
| DE602008004276D1 (de) | Luftkanone | |
| BRPI0922842A2 (pt) | prendedor com grampo antirrotação | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| ZA201004216B (en) | Glycine transporter-1 inhibitors | |
| DE602006013106D1 (de) | Magnetowiderstandsvorrichtung | |
| DE602008005825D1 (de) | Luftdruckwaffe | |
| FI20075546L (fi) | Ylläpitojärjestelmä | |
| BRPI0919200A2 (pt) | derivado de aminoácido | |
| BRPI0814800A2 (pt) | Derivados de aminoácidos | |
| DK1991718T3 (da) | Korrosionsinhibitorer | |
| DE602006014927D1 (de) | Prüfvorrichtung | |
| ZA200810599B (en) | Glycine transporter-1 inhibitors | |
| BRPI0921795A2 (pt) | inibidores radiomarcados do transportador de glicina 1 | |
| FI20070926A0 (fi) | Transportterimääritys | |
| DK2081952T3 (da) | Peptider | |
| LU91233B1 (de) | Laderaumsystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/10/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2693 DE 16-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |